Impact of the coronavirus infectious disease (COVID-19) pandemic on the provision of inflammatory bowel disease (IBD) antenatal care and outcomes of pregnancies in women with IBD.
Christian Philipp SelingerAileen FraserPaul CollinsMelanie GunnThean Soon ChewGeorgina KerryKamal V PatelMaya RoysamKlaartje Bel KokAaron BancilVeronica HallRachel CooneyLyn SmithHelen SteedJonathan SegalAlexandra KentJimmy LimdiShaji SebastianPublished in: BMJ open gastroenterology (2021)
IBD antenatal care adjustments during the COVID-19 pandemic have not negatively affected patient care. Despite high levels of immunosuppression, only a single COVID-19 infection occurred. Adverse pregnancy outcomes were infrequent.
Keyphrases
- pregnancy outcomes
- pregnant women
- palliative care
- preterm birth
- infectious diseases
- healthcare
- ulcerative colitis
- quality improvement
- sars cov
- pain management
- gestational age
- type diabetes
- metabolic syndrome
- emergency department
- chronic pain
- adipose tissue
- skeletal muscle
- respiratory syndrome coronavirus
- adverse drug
- health insurance
- insulin resistance